23andMe CEO Anne Wojcicki on Glaxo Partnership and Data Security

Sep.05 -- Anne Wojcicki, 23andMe's chief executive officer, sits down with Bloomberg's Emily Chang at the TechCrunch Disrupt conference in San Francisco to discuss how the company hopes to leverage its technology in a partnership with GlaxoSmithKline Plc and the importance of data security.